Virtual Library

Start Your Search

  • WCLC 2018

    19th World Conference on Lung Cancer

    Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON

    Presentation Date(s):  
    • Sept 23 - 26, 2018
    • Total Presentations: 2384

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    OA02 - Novel Therapies in ROS1, HER2 and EGFR

    • Type: Oral Abstract Session
    • Track: Targeted Therapy
    • Presentations: 8
    • Coordinates: 9/24/2018, 10:30 - 12:00, Room 105
    • +

      OA02.01 - Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

      10:30 - 10:40  |  Presenter: Robert C. Doebele

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA04 - Novel Approaches with IO

    • Type: Mini Oral Abstract Session
    • Track: Immunooncology
    • Presentations: 12
    • Coordinates: 9/24/2018, 13:30 - 15:00, Room 107
    • +

      MA04.03 - Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) with Oncogenic Driver Mutations: New Results from the Global IMMUNOTARGET Registry

      13:40 - 13:45  |  Presenter: Oliver Gautschi

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA05 - Clinical Trials in IO

    • Type: Oral Abstract Session
    • Track: Advanced NSCLC
    • Presentations: 8
    • Coordinates: 9/24/2018, 13:30 - 15:00, Room 106
    • +

      OA05.05 - Avelumab vs Docetaxel for Previously Treated Advanced NSCLC: Primary Analysis of the Phase 3 JAVELIN Lung 200 Trial

      14:15 - 14:25  |  Presenter: Fabrice Barlesi

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA09 - Prevention and Cessation

    • Type: Oral Abstract Session
    • Track: Prevention and Tobacco Control
    • Presentations: 8
    • Coordinates: 9/24/2018, 15:15 - 16:45, Room 205 BD
    • +

      OA09.06 - Molecular Alterations and Estimated Indoor Radon in NSCLC Patients from the French National Cancer Institute Registry: Radon France Study

      16:10 - 16:20  |  Presenter: Laura Mezquita

      • Abstract
      • Presentation

      Loading...

      Information from this presentation has been removed upon request of the author.

      Information from this presentation has been removed upon request of the author.

  • +

    P1.01 - Advanced NSCLC (Not CME Accredited Session)

    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 112
    • Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
    • +

      P1.01-04 - Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients

      16:45 - 18:00  |  Presenter: Fabrice Barlesi

      • Abstract

      Loading...

    • +

      P1.01-66 - Randomized Phase II Evaluating EGFR-TKI Associated with Anti-Estrogen in Women with Non-Squamous Advanced Stage NSCLC: IFCT-1003 LADIE Trial.

      16:45 - 18:00  |  Presenter: Julien Mazieres

      • Abstract

      Loading...

  • +

    OA12 - Novel Therapies in MET, RET and BRAF

    • Type: Oral Abstract Session
    • Track: Targeted Therapy
    • Presentations: 8
    • Coordinates: 9/25/2018, 15:15 - 16:45, Room 106
    • +

      OA12.05 - Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSé Trial.

      16:00 - 16:10  |  Presenter: Julien Mazieres

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MS26 - From Textbook to Practice Around the World

    • Type: Mini Symposium
    • Track: Treatment in the Real World - Support, Survivorship, Systems Research
    • Presentations: 5
    • Coordinates: 9/26/2018, 10:30 - 12:00, Room 205 AC
  • +

    P3.03 - Biology (Not CME Accredited Session)

    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 30
    • Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
    • +

      P3.03-27 - Somatic BRCA1/2 Mutations in Advanced NSCLC Patients: Description of a Sub-Population from the Ongoing Unicancer SAFIR02-Lung / IFCT-1301 Trial

      12:00 - 13:30  |  Presenter: Jordi Remon

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)

    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 47
    • Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
    • +

      P3.16-02 - Phase III Study of Canakinumab (ACZ885) as Adjuvant Therapy in Patients with Surgically Resected NSCLC

      12:00 - 13:30  |  Presenter: Edward B Garon

      • Abstract

      Loading...